Compounds that improve the ability of a vaccine to stimulate an immune response.
Vaccines, biologics, adjuvant
Agenus uses the power of the immune system to develop innovative product candidates against cancer. The company has assembled a broad portfolio of antibodies including checkpoint inhibitors and ...
Develops novel immune-modulating therapeutics and vaccine adjuvants targeting autoimmune and infectious diseases. Our research is focused on developing novel immune modulating therapies in ...
Develops novel protein biotherapeutics for a pipeline of products ranging from infectious disease vaccines and adjuvants to small molecule therapeutics.
Vaccine adjuvant technology
IDRI performs research on tests for diagnosing disease, vaccines, and adjuvants, and screens drug candidates. The research is focused on pathogens that cause problems globally such as tuberculosis ...
TRIA’s core competencies encompass the discovery and research of immune-based therapeutics. Developing vaccines for influenza, nicotine, and more.